Table 1 Pathogenic variants

From: Pitfalls of clinical exome and gene panel testing: alternative transcripts

Variant

Gene

Panel transcript change

Alternative transcript change

AF

  

Type

Details

Type

Details

 

a) Variants in alternative coding regionsa

      

 chr19:13318673 delCTGCTGCTGCTGCTGCTGCTG

CACNA1A

UTR3

NM_001127221.1:c.*187_*167delCAGCAGCAGCAGCAGCAGCAG

Polyglutamine repeat

ENST00000614285.4_1:c.6973_6993del:p.2325_2331del

nab

 chr17:42987501 CAGCTAAC>GAT

GFAP

na

na

Frameshift

ENST00000435360.7_2:c.1292_1299ATC

0

 chr17:42987511C>T

GFAP

na

na

nonsynonymous

ENST00000435360.7_2:c.G1289A:p.R430H

8e-6

 chr6:39874535 delCT

MOCS1

UTR3

NM_005943.5:c.*366_*365delAG

Frameshift

ENST00000373195.7_1:c.1199_1200del:p.E400fs

2e-5

 chr6:39902057 delCC

MOCS1

na

na

Frameshift

ENST00000373188.6_1:c.99_100del:p.G33fs

0

 chr5:52404362G>A

MOCS2

na

NM_004531.4:c.-1358C>T

Stopgain

ENST00000361377.8_3:c.C130T:p.R44X

0

 chr5:52404386G>A

MOCS2

na

NM_004531.4:c.-1382C>T

Stopgain

ENST00000361377.8_3:c.C106T:p.Q36X

0

 chr5:52404404G>A

MOCS2

na

NM_004531.4:c.-1400C>T

Stopgain

ENST00000361377.8_3:c.C88T:p.Q30X

8e-6

 chr5:52404447A>T

MOCS2

na

NM_004531.4:c.-1443T>A

Nonsynonymous

ENST00000361377.8_3:c.T45A:p.S15R

8e-6

 chr5:52404459A>C

MOCS2

na

NM_004531.4:c.-1455T>G

Stopgain

ENST00000361377.8_3:c.T33G:p.Y11X

2e-5

 chr5:52404473C>A

MOCS2

UTR5

NM_004531.4:c.-1469G>T

Nonsynonymous

ENST00000361377.8_3:c.G19T:p.V7F

4e-6

 chr5:52405544G>A

MOCS2

UTR5

NM_004531.4:c.-2540C>T

Stopgain

ENST00000361377.8_3:c.C16T:p.Q6X

2e-5

 chr5:52405545 delGCACAGCGGCACCATCCCGCCTA

MOCS2

UTR5

NM_004531.4:c.-2541_-2563 delTAGGCGGGATGGTGCCGCTGTGC

Startloss

ENST00000361377.8_3:c.-8_15del23

0

 chr5:52405557C>T

MOCS2

na

NM_004531.4:c.-2553G>A

Startloss

ENST00000361377.8_3:c.G3A:p.M1I

0

 chr5:52405559T>C

MOCS2

na

NM_004531.4:c.-2555A>G

Startloss

ENST00000361377.8_3:c.A1G:p.M1V

1e-5

 chr9:130453077 delC

STXBP1

UTR3

NM_003165.3:c.*40delC

Frameshift

ENST00000373299.4_1:c.1726delC:p.Q576fs

0

b) Reannotated variantsa,c

 chrX:18646710C>T

CDKL5

Splicing

NM_003159.2:c.2713+3C>T

Stopgain

ENST00000623535.1_2:c.C2716T:p.Q906X

0

 chrX:76952065C>A

ATRX

Nonsynonymous

NM_000489.4:c.G370T:p.G124C

Stopgain

ENST00000395603.7_1:c.G370T:p.E124X

0

 chr3:33106965A>T

GLB1

Nonsynonymous

NM_000404.3:c.T542A:p.I181K

Stopgain

ENST00000307377.12_1:c.T330A:p.Y110X

0

 chr5:52402972G>A

MOCS2

Synonymous

NM_004531.4:c.C33T:p.F11F

Stopgain

ENST00000361377.8_3:c.C220T:p.Q74X

0

  1. AF allele frequency in gnomAD, UTR3 3’ untranslated region, UTR5 5’ untranslated region.
  2. aVariant sources and data supporting pathogenicity are provided in Supplementary Table S3.
  3. bThe variant is located in a low complexity region that may be difficult to sequence.
  4. cConstraint metrics reflecting the probability of intolerance to loss-of-function variation are provided in Supplementary Table S4.